Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Healthcare Stock Is Sending More Cash to Its Shareholders: Should You Buy It?


The primary objective of dividend growth investing is to build an investment portfolio that can provide an investor with reliable and growing streams of passive income. The dividends can be used however the investor would like -- paying bills, saving in the bank, or reinvesting in more shares.

Medical devices maker (NYSE: SYK) is an excellent dividend growth stock. This is evidenced by the fact that its dividend, payable on July 31, will be 7.9% higher compared to the previous year. But is the stock a buy for dividend growth investors?

Let's analyze Stryker's fundamentals and valuation to get an answer. 

Continue reading


Source Fool.com

Stryker Corp. Stock

€304.40
-0.070%
With only a change of -€0.200 (-0.070%) the Stryker Corp. price is nearly unchanged from yesterday.
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
As a result the target price of 335 € shows a slightly positive potential of 10.05% compared to the current price of 304.4 € for Stryker Corp..
Like: 0
SYK
Share

Comments